Closed-Loop Anesthesia, Using Bispectral Index as the Control Variable, During Liver Transplantation (Drone-TH)
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | May 21, 2007 | ||||
| Last Updated Date | March 12, 2009 | ||||
| Start Date ICMJE | May 2007 | ||||
| Estimated Primary Completion Date | September 2009 (final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures ICMJE |
consumption of propofol during anesthesia maintenance [ Time Frame: during anesthesia maintenance ] [ Designated as safety issue: No ] | ||||
| Original Primary Outcome Measures ICMJE |
consumption of propofol during anesthesia maintenance [ Time Frame: during anesthesia maintenance ] | ||||
| Change History | Complete list of historical versions of study NCT00477347 on ClinicalTrials.gov Archive Site | ||||
| Current Secondary Outcome Measures ICMJE |
- consumption of remifentanil - target modifications - hemodynamic events - volume loading and transfusion - extubation time, explicit memorization - time passed at BIS between 40 and 60 - MDAPE, wobble - global score - dysfunction of each system. [ Time Frame: during anesthesia maintenance ] [ Designated as safety issue: No ] | ||||
| Original Secondary Outcome Measures ICMJE |
- consumption of remifentanil - target modifications - hemodynamic events - volume loading and transfusion - extubation time, explicit memorization - time passed at BIS between 40 and 60 - MDAPE, wobble - global score - dysfunction of each system. [ Time Frame: during anesthesia maintenance ] | ||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title ICMJE | Closed-Loop Anesthesia, Using Bispectral Index as the Control Variable, During Liver Transplantation | ||||
| Official Title ICMJE | Comparison of Manual Propofol and Remifentanil Administration and Dual Closed-Loop, Using Bispectral Index as the Control Variable, During Liver Transplantation | ||||
| Brief Summary | To compare closed-loop anesthesia to manual administration of propofol and remifentanil during liver transplantation |
||||
| Detailed Description | The Bispectral Index (BIS) is an electroencephalogram-derived measure of anesthetic depth. We hypothesized that BIS can also indicate the adequacy of analgesia. Therefore we built a combined closed-loop anesthesia system using BIS as control variable and two proportional-differential control algorithms, a propofol and a remifentanil target-controlled infusion system. The effectiveness of such a closed-loop anesthesia system has been demonstrated in a prospective, randomized study. Elimination of anesthetic agents, propofol in particular, is strongly reduced during liver transplantation. Closed-loop anesthesia could provide adequacy for requirements in respect to the various phases of transplantation. Two groups of patients are compared: one in which propofol and remifentanil are administered by the anesthesiologist, using target-controlled infusion systems, and one in which propofol and remifentanil are administered automatically by the combined closed-loop anesthesia system. In both groups the goal is to maintain BIS between 40 and 60, the range recommended by the manufacturer during anesthesia. We expect the combined closed-loop anesthesia system group to do better: i.e. diminished consumption of propofol (primary outcome measure). |
||||
| Study Type ICMJE | Interventional | ||||
| Study Phase | Phase 4 | ||||
| Study Design ICMJE | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Subject) Primary Purpose: Treatment |
||||
| Condition ICMJE | Liver Transplantation | ||||
| Intervention ICMJE |
|
||||
| Study Arm (s) |
|
||||
| Publications * |
|
||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Withdrawn | ||||
| Estimated Enrollment ICMJE | 40 | ||||
| Estimated Completion Date | September 2009 | ||||
| Estimated Primary Completion Date | September 2009 (final data collection date for primary outcome measure) | ||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
| Gender | Both | ||||
| Ages | 18 Years and older | ||||
| Accepts Healthy Volunteers | No | ||||
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||
| Location Countries ICMJE | France | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT00477347 | ||||
| Other Study ID Numbers ICMJE | 2006/37 | ||||
| Has Data Monitoring Committee | No | ||||
| Responsible Party | Marc Fischler, Hopital Foch | ||||
| Study Sponsor ICMJE | Hopital Foch | ||||
| Collaborators ICMJE | Not Provided | ||||
| Investigators ICMJE |
|
||||
| Information Provided By | Hopital Foch | ||||
| Verification Date | March 2009 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||